iCAN: ISRAEL-CANNABIS IS DESIGNED TO DRIVE WORLDCLASS CANNABIS STARTUPS AND SOLUTIONS
TO THE GLOBAL MARKET.

iCAN’S MISSION IS TO IDENTIFY, INVEST, ACCELERATE AND SHOWCASE CANNABIS INNOVATION FOR THE GLOBAL CANNABIS ECONOMY.

CANNATECH IS MORE THAN JUST AN EVENT
...IT'S A THRIVING, GLOBAL ECOSYSTEM.

 

ABOUT US

 

iCAN’s mission is to IDENTIFY, INVEST, ACCELERATE and SHOWCASE cannabis innovation for the global cannabis economy.

iCAN uses our unique position in the industry to identify the most promising startups and innovators. We provide MENTORSHIP from CONCEPT to production and provide all the tools needed to CREATE WORLD CLASS PRODUCTS for the Global Cannabis market.

We are a tight TEAM of dedicated and PASSIONATE professionals who work hard to make a POSITIVE & LASTING IMPACT on the cannabis industry.

WE BELIEVE STRONGLY IN THE HEALING POTENTIAL OF MEDICAL CANNABIS AND THE ANCILLARY OPPORTUNITY AROUND THIS GREAT PLANT.

CHECK OUT HIGHLIGHTS FROM CANNATECH 2016

ISRAEL CANNABIS IN THE NEWS

THE LATEST FROM OUR BLOG

A Personal Response to Cannabis Industry Hopefuls

To the 119 people (yes, I counted) who have reached out to me personally over the last 18 months looking for work or entry to the cannabis space. This post is for you. This is not a sales letter. This is me, telling you what I actually think about your potential...

Who’s afraid of Big Bad Pharma?

Plant, Synthetic, Biosynthetic…the holy medical cannabis trinity By Clifton Flack, iCAN Founder & CMO Among the cannabis industry there’s few friends of big pharmaceutical conglomerates.  Advocates of whole plant over chemically lab manufactured molecules...

CannaTech 2017: Optimizing Drug Delivery for Medical Cannabis

Pharma and life sciences industry veteran Dr. Doron Friedman dives into existing drug delivery technologies for the oral bioavailability of cannabinoids Dr. Doron Friedman explores the integration of pharmaceutical technologies and delivery systems into the evolving...

Debuting Kanabo Research and VapePod™ at CannaTech 2017

Medical cannabis R&D startup Kanabo Research comes out of stealth mode with game changing, trusted formulations and vaporization solutions for the medical industry. Avihu Tamir, CEO of Kanabo Research, presents his new venture’s pioneering technologies in...

CannaTech 2017: Combating Epilepsy and Brain Cancer with Cannabinoids

World-renowned pharmacologist Dr. Nephi Stella presents his groundbreaking research Dr. Nephi Stella, Professor of Pharmacology, Psychiatry and Behavioral Sciences at the University of Washington and CEO of Stella Therapeutics shares his findings on the effects...

THE LATEST FROM OUR BLOG

A Personal Response to Cannabis Industry Hopefuls

To the 119 people (yes, I counted) who have reached out to me personally over the last 18 months looking for work or entry to the cannabis space. This post is for you. This is not a sales letter. This is me, telling you what I actually think about your potential...

Who’s afraid of Big Bad Pharma?

Plant, Synthetic, Biosynthetic…the holy medical cannabis trinity By Clifton Flack, iCAN Founder & CMO Among the cannabis industry there’s few friends of big pharmaceutical conglomerates.  Advocates of whole plant over chemically lab manufactured molecules...

CannaTech 2017: Optimizing Drug Delivery for Medical Cannabis

Pharma and life sciences industry veteran Dr. Doron Friedman dives into existing drug delivery technologies for the oral bioavailability of cannabinoids Dr. Doron Friedman explores the integration of pharmaceutical technologies and delivery systems into the evolving...

Debuting Kanabo Research and VapePod™ at CannaTech 2017

Medical cannabis R&D startup Kanabo Research comes out of stealth mode with game changing, trusted formulations and vaporization solutions for the medical industry. Avihu Tamir, CEO of Kanabo Research, presents his new venture’s pioneering technologies in...

CannaTech 2017: Combating Epilepsy and Brain Cancer with Cannabinoids

World-renowned pharmacologist Dr. Nephi Stella presents his groundbreaking research Dr. Nephi Stella, Professor of Pharmacology, Psychiatry and Behavioral Sciences at the University of Washington and CEO of Stella Therapeutics shares his findings on the effects...

Pin It on Pinterest

REGISTER NOW

Register for iCAN & CannaTech Updates-n-Offers

Use promo code CANNA25 for a 25% discount

You have Successfully Subscribed!